Drugs / Ad5.ENVA.48
last change Oct 2016 re-read 3 minutes ago

Ad5.ENVA.48

Developed for
HIV infectious disease
Investigated by
National Institute of Allergy and Infectious Diseases (NIAID)

Trials 1

2009201020112012201320142015201620172018201920202021202220232024202520262027
PhaseRegistry idDatesIndicationSponsorStatusOutcome
Phase 1 NCT00695877 Feb 2009 → Dec 2012 HIV infectious disease National Institute of Allergy and Infectious Diseases (NIAID) Completed No outcome recorded

Evidence & citations 1 cited value

Every value below carries the sentence it was read from. 1 source stands behind the page.

FieldValueCited text
Known as Ad5.ENVA.48 ClinicalTrials.gov intervention name — accepted as the source's own label NCT00695877 ↗